Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Effect Of Semicrystalline Polymers On Self-emulsifying Solid Dispersions Of Nateglinide: In Vitro And In Vivo Evaluation

R. P. Swain, B. B. Subudhi
Published 2018 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract This study was undertaken to improve solubility and bioavailability of nateglinide by preparation of stable self-emulsifying solid dispersions (SESDs). The influence of semicrystalline polymers (poloxamer 407, gelucire 50/13) and method of preparation on dissolution behavior, in vivo performance and stability of nateglinide SESDs were investigated. After optimization, SESDs were prepared at 1:5 weight ratio of nateglinide and polymer individually. All the SESDs were characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction and scanning electron microscopy. Aqueous solubility of nateglinide was enhanced by 91.82-fold. The SESDs (poloxamer 407-based solid dispersions) achieved rapid and complete drug release (∼100% within 45 min) at pH 2. The improved dissolution appeared to be well correlated with the enhanced bioavailability of nateglinide in rabbits. After oral administration of SESDs (poloxamer 407-based solid dispersions), Cmax and AUC of nateglinide were increased by ∼2.92 and 1.77-folds, respectively, signifying the effectiveness of solid dispersions to improve the bioavailability of nateglinide. Stability during storage was established to show prevention of recrystallization. In conclusion, SESDs with poloxamer 407 in solvent method appeared to be an economic and promising technique to improve the dissolution, bioavailability, and stability of nateglinide.
This paper references
10.1016/S0168-3659(02)00009-3
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.
A. Kabanov (2002)
10.4103/0976-0105.177703
A simple practice guide for dose conversion between animals and human
A. Nair (2016)
10.1021/JS980403L
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.
A. T. Serajuddin (1999)
10.1016/J.JDDST.2017.01.005
Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
Mona F. Arafa (2017)
10.1016/j.jsps.2009.08.006
Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
M. Elbadry (2009)
10.1007/s12247-014-9181-6
Enhancement of Solubility and Dissolution Rate of Loratadine with Gelucire 50/13
S. Bandari (2014)
10.4172/JBB.1000027
Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs
Y. R. Krishnaiah (2010)
Poloxamers in the pharmaceutical industry. In: Tarcha PJ, editor. Polymers for controlled drug
IR Schmolka (1991)
Poloxamers in the pharmaceutical industry
I R Schmolka (1991)
10.1016/S0378-5173(01)00891-2
The mechanisms of drug release from solid dispersions in water-soluble polymers.
D. Craig (2002)
10.4103/2230-973X.96921
Improvement in solubility of poor water-soluble drugs by solid dispersion
Swati Sareen (2012)
10.1007/s11094-016-1386-1
A Review of Analytical Methods for the Determination of Nateglinide in Pharmaceuticals and Biological Samples
Basavaiah Kanakapura (2016)
10.1016/S0378-5173(99)00070-8
Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
V. Tantishaiyakul (1996)
10.3109/9781420017267-10
Lipid-Based Self-Emulsifying Solid Dispersions
Madhav Vasanthavada (2007)
Pluronic V R block copolymers as novel polymer therapeutics for drug and gene delivery
A V Kabanov (2002)
10.1021/CG301447D
Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times
Grace A. Ilevbare (2013)
10.1016/j.ijpharm.2013.06.085
II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling.
L. Maggi (2013)
10.1021/mp200546p
Modification of crystallization behavior in drug/polyethylene glycol solid dispersions.
Q. Zhu (2012)
10.1007/978-1-4614-1144-4_8
Structured Development Approach for Amorphous Systems
N. Shah (2012)
10.1016/j.ejpb.2008.05.023
Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Hajime Konno (2008)
Pharmacokinetic parameters of pure drug nateglinide and poloxamer 407 based SESDs (SM) in rabbits (mean ± SD
10.3109/9781420017267
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs
J. Dressman (2007)
10.1016/j.ijpharm.2010.03.014
Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions.
W. Ali (2010)
10.1016/S0378-5173(02)00532-X
Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.
S. Verheyen (2002)
Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
José Juan Escobar-Chávez (2006)
10.1007/s10973-015-4714-x
Improving water solubility of nateglinide by complexation of β-cyclodextrin
H. Ikeda (2015)
10.1208/s12249-012-9887-z
Lyophilized Oral Sustained Release Polymeric Nanoparticles of Nateglinide
Mohammad Kaleemuddin (2012)
10.1016/J.TRAC.2013.06.002
Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions
Y. Guo (2013)
10.1208/s12249-012-9868-2
Solid Dispersion of Ursolic Acid in Gelucire 50/13: a Strategy to Enhance Drug Release and Trypanocidal Activity
J. O. Eloy (2012)
10.1016/J.IJPHARM.2007.05.031
Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
Madhuri Newa (2007)
Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs
Wagh Vinod Tukaram (2013)
10.1208/s12249-011-9711-1
Optimization of a Dual Mechanism Gastrofloatable and Gastroadhesive Delivery System for Narrow Absorption Window Drugs
Caragh S Murphy (2011)
10.1016/j.ijpharm.2012.06.060
Solubility enhancement of desloratadine by solid dispersion in poloxamers.
Nemanja Kolašinac (2012)
10.1016/j.cmpb.2010.01.007
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Y. Zhang (2010)
10.1016/s0378-5173(96)04687-x
Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
V. Tantishaiyakul (1999)
10.1016/j.jpba.2010.12.003
Determination of the nateglinide polymorphic purity through DSC.
G. Bruni (2011)
10.1208/pt060350
Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique
B. Chauhan (2008)
10.1016/j.ijpharm.2013.06.084
I. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: nanoparticles and co-mixing.
L. Maggi (2013)
10.1081/PDT-120000291
Evaluation and Selection of Bio-relevant Dissolution Media for a Poorly Water-Soluble New Chemical Entity
L. Tang (2001)
PluronicR block copolymers as novel polymer therapeutics for drug and gene delivery
AV Kabanov (2002)
10.1002/BMC.351
Study on the bioavailability of nateglinide-hydroxypropyl-beta-cyclodextrin complex capsule in rabbits by liquid chromatographic-tandem mass spectrometry.
Z. He (2004)
10.13189/ADM.2013.010302
Enhancement of Solubility with Formulation & in-vitro Evaluation of Oral Nateglinide Compacts by Liquisolid Technique
M. Vinod (2013)
10.1002/jps.21650
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
J. Brouwers (2009)
10.1016/j.ijpharm.2014.09.013
Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
N. Ramadhani (2014)
10.1080/10837450.2016.1265554
Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method
Muhammad Tayyab Ansari (2018)
10.1016/S0939-6411(00)00076-X
Improving drug solubility for oral delivery using solid dispersions.
C. Leuner (2000)
10.1016/J.POWTEC.2013.11.017
Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods
J. O. Eloy (2014)
10.1093/ajhp/42.5.1206
Pharmaceutical Statistics: Practical and Clinical Applications
M. Montagne (1985)
10.1007/s10973-011-1299-x
Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients
N. R. Pani (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar